PMC:7652766 / 89115-89345
Annnotations
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T435 | 0-230 | Sentence | denotes | Conversely, Cao et al. (313) conducted a controlled open‐label study with 199 hospitalized severe COVID‐19 patients randomly divided into two groups: a standard care group and a lopinavir/ritonavir treatment group (400 mg/100 mg). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3238 | 107-115 | Species | denotes | patients | Tax:9606 |
| 3240 | 176-177 | Gene | denotes | a | Gene:351 |
| 3241 | 150-151 | Gene | denotes | a | Gene:351 |
| 3242 | 39-40 | Gene | denotes | a | Gene:351 |
| 3243 | 178-197 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 3247 | 98-106 | Disease | denotes | COVID‐19 | MESH:C000657245 |